{"id":16339,"date":"2021-12-06T10:18:30","date_gmt":"2021-12-06T10:18:30","guid":{"rendered":"https:\/\/zeepedia.com\/?p=16339"},"modified":"2021-12-09T07:07:47","modified_gmt":"2021-12-09T07:07:47","slug":"lemtrada","status":"publish","type":"post","link":"https:\/\/zeepedia.com\/medical\/medicines\/lemtrada\/","title":{"rendered":"LEMTRADA &#8211; Alemtuzumab uses, dose and side effects"},"content":{"rendered":"\n<p>12 mg&nbsp;concentrate for&nbsp;infusion&nbsp;solution<br>alemtuzumab<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What LEMTRADA is and what it is used for<\/h2>\n\n\n\n<p>LEMTRADA contains the active substance alemtuzumab used to treat a form of\u00a0multiple sclerosis\u00a0(MS) in adults, called relapsing-remitting\u00a0multiple sclerosis\u00a0(RRMS, relapsing-remitting MS).\u00a0LEMTRADA does not cure MS but can reduce the number of\u00a0relapses\u00a0of MS.\u00a0LEMTRADA can also help slow down or reverse certain signs and symptoms of MS.\u00a0In\u00a0clinical trials, patients treated with LEMTRADA had fewer\u00a0relapses\u00a0and were less likely to have impaired function compared with patients treated with a beta-interferon\u00a0injected several times a week.<\/p>\n\n\n\n<p>LEMTRADA is used if your MS is highly active even though you have been treated with at least one other MS medicine or if your MS worsens rapidly.<\/p>\n\n\n\n<p><strong>What is\u00a0multiple sclerosis<\/strong>?<br>Multiple sclerosis, MS, is an\u00a0autoimmune\u00a0disease that affects the\u00a0central nervous system\u00a0(brain and spinal cord).\u00a0MS means that your immune system accidentally attacks the protective layer (myelin) around the nerve fibers and causes\u00a0inflammation.\u00a0When\u00a0inflammation\u00a0causes symptoms, it is often called an attack or a\u00a0relapse.\u00a0Patients with RRMS experience\u00a0relapses\u00a0that are followed by periods of recovery.<\/p>\n\n\n\n<p>What symptoms you experience depends on which part of your central nervous system is affected.&nbsp;The damage that occurs to your nerves during this&nbsp;inflammation&nbsp;can go back, but as the disease progresses, the damage can build up and become permanent.<\/p>\n\n\n\n<p><strong>How LEMTRADA works<\/strong><br>LEMTRADA regulates your immune system to limit attacks on the nervous system.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What you need to know before you get LEMTRADA<\/h2>\n\n\n\n<h2 class=\"wp-block-heading\">DO NOT use LEMTRADA:<\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>if you are allergic to alemtuzumab or any of the other ingredients of this medicine (listed in section 6)<\/li><li>if you are infected with human immunodeficiency virus (&nbsp;HIV&nbsp;).<\/li><li>if you suffer from a serious&nbsp;infection<\/li><li>if you have any of the following conditions:<ul><li>other&nbsp;autoimmune&nbsp;disease besides&nbsp;multiple sclerosis<\/li><li>untreated high&nbsp;blood pressure<\/li><li>previously had ruptures in blood vessels that supply the brain<\/li><li>previously had a&nbsp;stroke<\/li><li>previously had a heart attack or chest pain<\/li><li>previously had bleeding disorders<\/li><\/ul><\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Warnings and cautions<\/h2>\n\n\n\n<p>Talk to your doctor before receiving LEMTRADA.\u00a0After receiving treatment with LEMTRADA, you may be at greater risk of developing other autoimmune conditions or serious\u00a0infections.\u00a0It is important that you understand these risks and how to keep them under control.\u00a0You will receive a patient warning card and a patient guide with additional information.\u00a0It is important that you always\u00a0carry the Patient Alert Card\u00a0with you during treatment and for four years after your last\u00a0infusion\u00a0of LEMTRADA, as\u00a0side effects\u00a0may occur several years after treatment.\u00a0You should always show the patient warning card to your doctor when receiving medical treatment, even if it is not for your MS.<\/p>\n\n\n\n<p>Your doctor will take blood samples before you start treatment with LEMTRADA.&nbsp;The purpose of the tests is to find out if you can take LEMTRADA.&nbsp;Your doctor also wants to make sure that you do not have any medical conditions or diseases before starting treatment with LEMTRADA.<br><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>Autoimmune conditions<\/strong><\/li><\/ul>\n\n\n\n<p>Treatment with LEMTRADA may increase the risk of autoimmune conditions.&nbsp;Such conditions mean that the immune system accidentally attacks your body.&nbsp;Below you will find information on certain specific conditions that have been observed in MS patients who have been treated with LEMTRADA.<\/p>\n\n\n\n<p>These autoimmune conditions can occur several years after treatment with LEMTRADA.\u00a0Therefore, you must leave regular blood and urine tests for four years after your last\u00a0infusion.\u00a0These tests are needed even if you are feeling well and if your MS symptoms are under control.\u00a0There are certain signs and symptoms that you should keep an eye out for.\u00a0In addition, these conditions can occur later than 4 years after the end of treatment and you must therefore continuously look for signs and symptoms, even after you no longer need to leave monthly blood and urine tests.\u00a0Detailed information on these signs and symptoms, the sampling, and measures you need to take can be found in sections 2 and 4 &#8211;\u00a0<em>autoimmune conditions.<\/em><\/p>\n\n\n\n<p>Further useful information on these autoimmune conditions and how to test for them can be found in the\u00a0<strong>LEMTRADA Patient Guide<\/strong>.<br><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>Acquired&nbsp;haemophilia&nbsp;(&nbsp;haemophilia&nbsp;A)<\/strong>In rare cases, patients have developed a&nbsp;<strong>bleeding disorder<\/strong>&nbsp;, which is caused by&nbsp;antibodies&nbsp;that act against&nbsp;factor VIII&nbsp;(a&nbsp;protein&nbsp;needed for normal blood coagulation), which is called acquired&nbsp;hemophilia&nbsp;(&nbsp;hemophilia&nbsp;A).&nbsp;This condition needs to be diagnosed and treated immediately.&nbsp;Symptoms of acquired&nbsp;haemophilia&nbsp;are described in section 4.<\/li><li><strong>Immunological&nbsp;thrombocytopenia&nbsp;(ITP)<\/strong><br>A common side effect is that patients develop a&nbsp;<strong>bleeding disorder<\/strong>&nbsp;that is caused by a low level of&nbsp;platelets&nbsp;and is called immunological&nbsp;thrombocytopenia&nbsp;(ITP).&nbsp;This disease must be diagnosed and treated early, otherwise the effects can be&nbsp;<strong>serious or even fatal<\/strong>&nbsp;.&nbsp;A description of the signs and symptoms of ITP can be found in section 4.<\/li><li><strong>Kidney disease (eg anti-GBM disease)<\/strong><br>In rare cases, patients have experienced autoimmune reactions that have caused&nbsp;<strong>kidney<\/strong>&nbsp;problems&nbsp;, such as antiglomerular basement membrane disease (anti-GBM disease).&nbsp;A description of the signs and symptoms of kidney disease can be found in section 4. If left untreated, it can cause&nbsp;kidney failure&nbsp;that requires&nbsp;dialysis&nbsp;or transplantation, and can lead to death.<\/li><li><strong>Thyroid disorders<\/strong><br>are very common that patients experienced an&nbsp;autoimmune&nbsp;disorder of&nbsp;<strong>the thyroid gland<\/strong>&nbsp;which affects its ability to form or to check&nbsp;hormone&nbsp;you that are important for metabolism.<br>LEMTRADA can cause various types of thyroid disorders, including:<ul><li><strong>Overactive&nbsp;thyroid gland&nbsp;<\/strong>(&nbsp;hyperthyroidism&nbsp;), where the thyroid gland produces too much&nbsp;hormone<\/li><li><strong>Underactive&nbsp;thyroid gland<\/strong>&nbsp;(&nbsp;hypothyroidism&nbsp;), where the thyroid gland does not produce enough&nbsp;hormone&nbsp;.<\/li><\/ul><\/li><\/ul>\n\n\n\n<p>A description of the signs and symptoms of thyroid disorders can be found in section 4.<\/p>\n\n\n\n<p>If you develop a thyroid disorder, in most cases you will need to be treated for the rest of your life with drugs that control the thyroid disorder, and in some cases, the thyroid gland may need to be removed.<\/p>\n\n\n\n<p>You must get the right treatment for thyroid disorders, especially if you become pregnant after using LEMTRADA.\u00a0If you have an untreated thyroid disorder, this can harm the fetus or the newborn baby.<br><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>Liver inflammation<\/strong>Some patients have developed hepatitis after receiving LEMTRADA.Hepatitis can be diagnosed from the blood samples that you must take regularly after treatment with LEMTRADA.&nbsp;Tell your doctor if you develop one or more of the following symptoms: nausea, vomiting, abdominal pain, fatigue, loss of appetite, yellow skin or eyes, dark urine or bleeding or if you get bruises more easily than normal.<br><\/li><li><strong>Thrombotic thrombocytopenic purpura (TTP)<\/strong>A thrombotic disease called thrombotic thrombocytopenic purpura (TTP) can occur during treatment with LEMTRADA.&nbsp;Blood clots form in blood vessels and can occur throughout the body.&nbsp;Contact your healthcare provider immediately if you have any of the following symptoms: bruising of the skin or mouth that may appear as small red dots, with or without unexplained extreme fatigue, fever, confusion, speech changes, yellowing of the skin or eyes (jaundice), small amount of urine, dark-colored urine.&nbsp;It is recommended to seek medical attention immediately as TTP can be fatal (see section 4 \u201cPossible side effects\u201d).<br><\/li><li><strong>Sarcoids<\/strong>There have been reports of an immune system disease (&nbsp;sarcoidosis&nbsp;) in patients treated with LEMTRADA.&nbsp;Symptoms may include persistent dry cough, shortness of breath, chest pain, fever, swollen&nbsp;lymph nodes&nbsp;, weight loss, rash and blurred vision.<br><\/li><li><strong>Other autoimmune conditions<\/strong><br>In less common cases, patients have experienced autoimmune conditions involving&nbsp;<strong>red or&nbsp;white blood cells<\/strong>&nbsp;.&nbsp;This can be diagnosed from the blood samples that you need to take regularly after treatment with LEMTRADA.&nbsp;If you develop any of these conditions, your doctor will tell you and take appropriate action to treat the condition.<\/li><li><strong>Infusion reactions<\/strong><br>Most patients treated with LEMTRADA experience&nbsp;side effects&nbsp;during the&nbsp;infusion&nbsp;itself&nbsp;or within 24 hours after the&nbsp;infusion&nbsp;.&nbsp;To try to reduce the infusion reactions, your doctor will give you some medicine or other medicines (see section 4 &#8211;&nbsp;<em>infusion reactions<\/em>&nbsp;).<\/li><\/ul>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>Other serious reactions that occur shortly after&nbsp;infusion&nbsp;one of LEMTRADA<\/strong>Some people have had severe or life-threatening reactions after&nbsp;infusion of&nbsp;one of LEMTRADA, including bleeding in the lungs, heart attack,&nbsp;stroke&nbsp;or rupture of blood vessels that supply the brain.&nbsp;Reactions may occur after any of the&nbsp;doses&nbsp;during the treatment regimen.&nbsp;In a majority of cases, the reactions have occurred within 1-3 days after&nbsp;infusion&nbsp;one.&nbsp;Your doctor will monitor vital parameters, including blood pressure before and during&nbsp;infusion&nbsp;one.&nbsp;Get help immediately if you have any of the following symptoms: difficulty breathing, coughing up blood, chest pain, drooping face, sudden severe headache, weakness in one half of the body, difficulty speaking or neck pain.<\/li><li><strong>Hemophagocytic lymphohistiocytosis<\/strong>Treatment with LEMTRADA may increase the risk of excessive activation of&nbsp;white blood cells&nbsp;in association with&nbsp;inflammation&nbsp;(haemophagocytic lymphohistiocytosis), which may be fatal if not diagnosed and treated early.&nbsp;If you experience multiple symptoms such as fever, swollen&nbsp;glands&nbsp;, bruising or rash, contact a doctor immediately.<\/li><li><strong>Infection&nbsp;s<\/strong><br>Patients treated with LEMTRADA are at higher risk of developing a<strong>&nbsp;serious&nbsp;infection<\/strong>&nbsp;(see section 4 &#8211;<em>&nbsp;Infection&nbsp;s<\/em>&nbsp;).&nbsp;In general, these&nbsp;infections can&nbsp;be treated with standard&nbsp;medicines&nbsp;.<\/li><\/ul>\n\n\n\n<p>To reduce the risk of you getting an\u00a0infection, your doctor will check if other medicines you are taking can affect your immune system.\u00a0Therefore, it is important that you tell your doctor about all the medicines you are taking.<\/p>\n\n\n\n<p>Tell your doctor if you have a serious\u00a0infection\u00a0before starting treatment with LEMTRADA as your\u00a0<strong>doctor will postpone treatment until\u00a0the <\/strong>infection\u00a0has passed.<\/p>\n\n\n\n<p>Patients treated with LEMTRADA are at higher risk of developing a herpes infection (for example,&nbsp;<strong>a cold sore<\/strong>&nbsp;).&nbsp;In general, a patient who has already had a herpes infection has a higher risk of developing a herpes infection again.&nbsp;It is also possible to develop a herpes infection for the first time.&nbsp;It is recommended that your doctor prescribe a medicine that reduces the risk of developing a herpes infection that you should take on the days when you receive treatment with LEMTRADA and for one month after treatment.<\/p>\n\n\n\n<p>In addition, there is the risk of developing\u00a0infection\u00a0that may lead to\u00a0<strong>changes in the cervix<\/strong>\u00a0(\u00a0cervical\u00a0).\u00a0Therefore, it is recommended that all female patients undergo an annual examination, such as cell samples.\u00a0The doctor explains what tests are needed.<\/p>\n\n\n\n<p>Infection\u00a0with a\u00a0virus\u00a0called\u00a0<strong>cytomegalovirus\u00a0<\/strong>has been reported in patients treated with LEMTRADA.\u00a0Most of the cases occurred within 2 months after the initial\u00a0dosing\u00a0of alemtuzumab.\u00a0Contact a doctor immediately if you get symptoms of infection such as fever or swollen\u00a0glands.<\/p>\n\n\n\n<p>Patients who have been treated with LEMTRADA have had an\u00a0infection\u00a0due to a\u00a0virus\u00a0called\u00a0<strong>Epstein-Barr\u00a0virus\u00a0(\u00a0EBV\u00a0)<\/strong>, including cases of severe and sometimes fatal hepatitis.\u00a0Contact a doctor immediately if you get symptoms of infection such as fever, swollen\u00a0glands,\u00a0or fatigue.<\/p>\n\n\n\n<p>Patients treated with LEMTRADA are also at higher risk of developing\u00a0<strong>listeria\u00a0<\/strong>infection\u00a0(a bacterial\u00a0infection\u00a0caused by eating contaminated food).\u00a0Listeria infection can cause serious illness, including &#8211;\u00a0meningitis\u00a0(\u00a0meningitis\u00a0) but can be treated with appropriate medication.\u00a0To reduce this risk, avoid eating raw or poorly cooked meat, mold and putty cheese, and unpasteurized dairy products two weeks before treatment, during treatment, and for at least one month after treatment with LEMTRADA.<\/p>\n\n\n\n<p>If you live in an area where\u00a0<strong>tuberculosis<\/strong>\u00a0infection\u00a0you are normal you may be at greater risk of\u00a0infection\u00a0with\u00a0tuberculosis.\u00a0Your doctor will arrange for\u00a0tuberculosis\u00a0checks.<\/p>\n\n\n\n<p>If you are a carrier of&nbsp;<strong>hepatitis&nbsp;B or&nbsp;hepatitis&nbsp;C&nbsp;infection<\/strong>&nbsp;(these diseases affect the liver) extra care must be taken before you can receive treatment with LEMTRADA, as it is unknown if the treatment could lead to the hepatitis infection being activated, which in that case can damage your liver.<\/p>\n\n\n\n<p>There have been cases of a rare brain infection called PML (&nbsp;progressive&nbsp;multifocal&nbsp;leukoencephalopathy) in patients receiving LEMTRADA.&nbsp;PML has been reported in patients with other risk factors, especially previous treatment with MS drugs associated with PML.<\/p>\n\n\n\n<p>PML can lead to severe disability for weeks or months and can be fatal.<\/p>\n\n\n\n<p>The symptoms may resemble a relapse of MS and include\u00a0progressive\u00a0weakness or clumsiness in the\u00a0extremities, visual disturbances, speech problems or changes in thinking, memory, and orientation that lead to confusion and personality changes.\u00a0It is important to inform your relatives or caregivers about your treatment, as they may notice symptoms that you are not aware of.\u00a0Contact a doctor immediately if you develop symptoms suggestive of PML.<br><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>Pneumonitis&nbsp;and pericarditis<\/strong>Pneumonitis&nbsp;(&nbsp;inflammation&nbsp;of lung tissue) has been reported in patients treated with LEMTRADA.&nbsp;Most cases occurred within the first month after treatment with LEMTRADA.&nbsp;Cases of pericardial effusion (accumulation of fluid around the heart) and pericarditis (pericarditis) have also been reported in patients treated with LEMTRADA.&nbsp;You should report symptoms such as shortness of breath, cough, wheezing, chest pain or tightness in the chest and bloody cough to your doctor, as they may be caused by&nbsp;pneumonitis&nbsp;, pericardial effusion or pericarditis.<\/li><li><strong>Inflammation&nbsp;of the gallbladder<\/strong>LEMTRADA may increase your risk of getting&nbsp;gallbladder&nbsp;inflammation&nbsp;.&nbsp;This can be a serious medical condition that can be life threatening.&nbsp;You should contact your doctor if you have symptoms such as abdominal pain or discomfort, fever, nausea or vomiting.<\/li><li><strong>Previous cancer diagnosis<\/strong><br>Tell your doctor if you have previously been diagnosed with cancer.<\/li><li><strong>Vaccine<\/strong><br>It is not known if LEMTRADA affects your vaccine response.&nbsp;If you have not received the usual standard vaccinations, your doctor will consider whether you should receive them before you receive LEMTRADA treatment.&nbsp;In particular, your doctor will consider vaccinating you against chickenpox if you have never had it.&nbsp;Any vaccinations must be given at least six weeks before starting a treatment course with LEMTRADA.<\/li><\/ul>\n\n\n\n<p>You must NOT take certain types of vaccines (&nbsp;<strong>live&nbsp;virus<\/strong><strong>&nbsp;vaccines<\/strong>&nbsp;) if you have recently received LEMTRADA.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Children and young people<\/h2>\n\n\n\n<p>LEMTRADA is not intended for use in children and adolescents under 18 years of age as it has not been studied in MS patients under 18 years of age.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Other medicines and LEMTRADA<\/h2>\n\n\n\n<p>Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines (including any vaccinations or herbal remedies).<\/p>\n\n\n\n<p>In addition to LEMTRADA, there are other treatments, both for MS and for the treatment of other conditions, that can affect your immune system and therefore affect your ability to fight\u00a0infection.\u00a0If you are taking such medicine, your doctor may ask you to stop taking that medicine before starting treatment with LEMTRADA.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Pregnancy<\/h2>\n\n\n\n<p>If you are pregnant, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.<\/p>\n\n\n\n<p>Women of childbearing potential must use effective contraception during each course of treatment with LEMTRADA and for four months after each course of treatment.<\/p>\n\n\n\n<p>If you become pregnant after treatment with LEMTRADA and suffer from a thyroid disorder during pregnancy, extra care is required.&nbsp;Thyroid disorders can harm the baby (see section 2&nbsp;<em>Warnings and precautions &#8211; autoimmune conditions).<\/em><\/p>\n\n\n\n<p><strong>Breast-feeding<\/strong><br>It is not known whether LEMTRADA can be transmitted to infants via breast milk, but there is a risk that this may be the case.\u00a0Therefore, it is recommended that you do not breastfeed during treatment with LEMTRADA and for four months after each course of treatment.\u00a0At the same time, there may be benefits to breast milk that can help protect\u00a0your\u00a0baby from\u00a0infection.\u00a0Therefore, talk to your doctor if you are planning to breastfeed your baby for advice on what is best for you and your baby.<\/p>\n\n\n\n<p><strong>Fertility<\/strong><br>During treatment and for four months afterward, LEMTRADA may remain in your body.\u00a0It is not known if LEMTRADA has any effect on\u00a0fertility\u00a0during this period.\u00a0Talk to your doctor if you are planning to become pregnant.\u00a0There is no evidence that LEMTRADA affects\u00a0male fertility.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Driving and using machines<\/h2>\n\n\n\n<p>Many patients experience&nbsp;side effects&nbsp;when they receive&nbsp;infusion&nbsp;one or within 24 hours after&nbsp;infusion&nbsp;one with LEMTRADA, and some of these, such as dizziness, may make it unsafe to drive or use machines.&nbsp;If you experience this, stop these activities until you feel better.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">LEMTRADA contains excipients<\/h2>\n\n\n\n<p>This medicine contains less than 1 mmol\u00a0<strong>potassium<\/strong>\u00a0(39 mg) per\u00a0infusion, ie essentially &#8216;potassium free.<br>This medicine contains less than 1 mmol\u00a0sodium\u00a0(23 mg) per\u00a0infusion, ie essentially &#8216;sodium-free.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">3. How to get LEMTRADA<\/h2>\n\n\n\n<p>Your doctor will explain to you how to get LEMTRADA.&nbsp;If you have any further questions, ask your doctor.<\/p>\n\n\n\n<p><strong>The initial treatment<\/strong>&nbsp;you will receive will consist of one&nbsp;infusion&nbsp;per day for 5 days (course 1) and one&nbsp;infusion&nbsp;per day for 3 days one year later (course 2).<\/p>\n\n\n\n<p>You will not receive any treatment with LEMTRADA between these two courses.&nbsp;Two treatment regimens can reduce MS activity for up to 6 years.<\/p>\n\n\n\n<p>Some patients with symptoms or signs of MS after the first two courses may receive one or two additional courses of treatment, consisting of one&nbsp;infusion&nbsp;per day for 3 days.&nbsp;These additional treatment regimens can be administered after twelve months or more after the previous regimens.<\/p>\n\n\n\n<p>The maximum daily dose is one\u00a0infusion.<\/p>\n\n\n\n<p>You will receive LEMTRADA as an\u00a0infusion\u00a0into a vein.\u00a0Each\u00a0infusion\u00a0takes about four hours.\u00a0Monitoring for\u00a0adverse reactions\u00a0and regular sampling must be continued for four years after the last\u00a0infusion.<\/p>\n\n\n\n<p>The diagram below can help you understand how long the effect of the treatment lasts and how long follow-up is required.<\/p>\n\n\n\n<figure class=\"wp-block-image\"><a href=\"https:\/\/www.fass.se\/LIF\/product?userType=2&amp;nplId=20121223000012#\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/www.fass.se\/imaging\/resources\/68fd1cfb-7dfb-416d-9d2a-5d400faab1ff\" alt=\"additional cures\" title=\"additional cures\"\/><\/a><\/figure>\n\n\n\n<p><strong>Follow-up after treatment with LEMTRADA<\/strong><br>Once you have received LEMTRADA, you must undergo regular tests to ensure that any\u00a0side effects\u00a0can be diagnosed and treated as soon as possible.\u00a0The tests must be continued for four years after the last\u00a0infusion.\u00a0See description in section 4 &#8211;\u00a0the most important\u00a0side effects\u00a0are.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">If you take more LEMTRADA than you should<\/h2>\n\n\n\n<p>Patients who have accidentally received too much LEMTRADA in an\u00a0infusion\u00a0have experienced severe reactions such as headache, rash, low\u00a0blood pressure,\u00a0or increased heart rate.\u00a0Doses\u00a0that are higher than the recommended\u00a0dose\u00a0may lead to more severe or prolonged infusion reactions (see section 4) or a more potent effect on the immune system.\u00a0In overdose, cancel the\u00a0administration\u00a0of LEMTRADA and treat the symptoms.<\/p>\n\n\n\n<p><strong>Missed&nbsp;<\/strong><strong>LEMTRADA&nbsp;dos&nbsp;er<\/strong><\/p>\n\n\n\n<p>Your\u00a0dose\u00a0is unlikely to\u00a0be missed as it is administered by healthcare professionals.\u00a0Note, however, that if a\u00a0dose is\u00a0missed, it should not be given on the same day as a scheduled\u00a0dose.<\/p>\n\n\n\n<p>If you have any further questions on the use of this product, ask your doctor.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Possible side effects<\/h2>\n\n\n\n<p>Like all medicines, this medicine can cause\u00a0side effects, although not everybody gets them.<\/p>\n\n\n\n<p>The&nbsp;<strong>main&nbsp;side effects&nbsp;are<\/strong>&nbsp;the&nbsp;<strong>autoimmune conditions<\/strong>&nbsp;described in section 2, including:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>Acquired\u00a0haemophilia\u00a0A (a type of\u00a0haemophilia\u00a0)<\/strong>\u00a0, (less common &#8211; may affect up to 1 in 100 people): may manifest as rapid bruising, nosebleeds, pain or swelling in joints, other types of bleeding or bleeding from a cuts take longer to stop than usual.<\/li><li><strong>ITP (bleeding disorder)<\/strong>\u00a0(common &#8211; may affect up to 1 in 10 people): may appear as small scattered red, pink or purple spots on the skin;\u00a0that you get bruises more easily;\u00a0that bleeding from wounds is more difficult to stop;\u00a0heavier, more prolonged or frequent menstrual bleeding than usual;\u00a0bleeding between periods;\u00a0bleeding from the gums or nose that has occurred recently or takes longer than usual to stop;\u00a0or coughing up blood.<\/li><li><strong>Thrombotic thrombocytope purpura (TTP),<\/strong>\u00a0(rare &#8211; may affect up to 1 in 1,000 people): may appear as bruises on the skin or on the mouth, which may appear as small red dots, with or without unexplained extreme fatigue, fever, confusion, speech changes, yellowing of the skin or eyes (jaundice), small amount of urine, dark-colored urine.<\/li><li><strong>kidney disease<\/strong>\u00a0(rare &#8211; may affect up to 1 in 1,000 people): may manifest as blood in the urine (your urine may be red or the same color as tea) or as swelling in the legs or feet.\u00a0It can also lead to damage to the lungs, which can result in you coughing up blood<\/li><\/ul>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td><strong>If you experience any of these signs or symptoms of bleeding or kidney disease, contact your doctor immediately and tell them about the symptoms.&nbsp;If you cannot reach your regular doctor, you must seek immediate medical attention immediately.<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>thyroid disorders<\/strong>\u00a0(very common &#8211; may affect more than 1 in 10 people): may manifest as excessive sweating;\u00a0unexplained weight loss or weight gain;\u00a0eye swelling;\u00a0nervousness;\u00a0fast heartbeat;\u00a0that one freezes;\u00a0fatigue that gets worse or recent constipation.<\/li><li><strong>disorders of red or\u00a0white blood cells<\/strong>\u00a0(uncommon &#8211; may affect up to 1 in 100 people): as a result of blood tests.<\/li><li><strong>sarcoidosis<\/strong>\u00a0(uncommon &#8211; may affect up to 1 in 100 people): may manifest as persistent dry cough, shortness of breath, chest pain, fever, swollen\u00a0lymph nodes\u00a0, weight loss, rash and blurred vision.<\/li><\/ul>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td>All of these serious&nbsp;side effects&nbsp;can occur several years after you have received LEMTRADA.&nbsp;<strong>If you experience any of these signs or symptoms, contact your doctor immediately and tell them about them.&nbsp;<\/strong>You will also have to take blood and urine samples regularly so that you can receive treatment quickly if you should suffer from&nbsp;<strong>any of these conditions.<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>You will be given the following tests for autoimmune conditions:<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><thead><tr><th scope=\"col\"><strong>Sample<\/strong><\/th><th scope=\"col\"><strong>When?<\/strong><\/th><th scope=\"col\"><strong>How long?<\/strong><\/th><\/tr><\/thead><tbody><tr><td><strong>Blood tests<br><\/strong>(to diagnose all-important serious\u00a0side effects\u00a0listed above)<\/td><td><strong><br>Before starting treatment and every month after treatment<\/strong><\/td><td><strong><br>Up to four years after your last LEMTRADA&nbsp;infusion<\/strong><\/td><\/tr><tr><td><strong>Urine test<br><\/strong>(additional test to diagnose kidney disease)<\/td><td><strong><br>Before starting treatment and every month after treatment<\/strong><\/td><td><strong><br>Up to four years after your last LEMTRADA&nbsp;infusion<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>After this period, your doctor will perform more tests if you experience symptoms of ITP, acquired\u00a0hemophilia\u00a0A, TTP, kidney, or thyroid disorders.\u00a0After four years, you should continue to pay attention to signs or symptoms of\u00a0side effects\u00a0as described in your patient guide, and you should continue to carry the patient warning card with you.<\/p>\n\n\n\n<p>Another\u00a0<strong>important\u00a0side effect<\/strong>\u00a0is the\u00a0<strong>increased risk of\u00a0infection\u00a0<\/strong>(see below for details on how often patients suffer from\u00a0infections\u00a0s).\u00a0These are usually mild, but\u00a0the <strong>severe\u00a0infection\u00a0<\/strong>may occur.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td><strong>Tell<\/strong>\u00a0your\u00a0<strong>doctor immediately if<\/strong>\u00a0you experience any of these signs of\u00a0infection fever and \/ or chillsswollen\u00a0glands<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>To reduce the risk of certain\u00a0infections, your doctor may consider giving you a chickenpox vaccination and\/or other vaccinations that your doctor considers necessary for you (see section 2:\u00a0What you need to know before you receive LEMTRADA &#8211; Vaccine).\u00a0Your doctor may also\u00a0<em>prescribe cold<\/em>\u00a0sores (see section 2:\u00a0<em>What you need to know before you get LEMTRADA &#8211;\u00a0Infections\u00a0).<\/em><\/p>\n\n\n\n<p>The\u00a0<strong>most common\u00a0side effects\u00a0are<\/strong>\u00a0infusion reactions\u00a0(see below for details on how often patients experience such), which may occur during the\u00a0infusion,\u00a0once or within 24 hours after\u00a0the infusion\u00a0a.\u00a0These are usually mild but severe reactions that can occur.\u00a0Sometimes allergic reactions can also occur.<\/p>\n\n\n\n<p>To try to reduce the infusion reactions, your\u00a0doctor will give you other medicines (\u00a0corticosteroids\u00a0) before the first three\u00a0infusions\u00a0of each LEMTRADA course of treatment.\u00a0Other treatments can limit these reactions and that you can get before\u00a0infusion\u00a0one or when you experience symptoms.\u00a0In addition, you will be monitored during\u00a0infusion\u00a0one and for two hours after the end of\u00a0infusion\u00a0one.\u00a0If you get severe reactions, you can slow down the\u00a0infusion\u00a0or stop it completely.<\/p>\n\n\n\n<p>More information on these reactions can be found in the&nbsp;<strong>LEMTRADA Patient Guide.<\/strong><\/p>\n\n\n\n<p>The&nbsp;<strong>side effect&nbsp;is<\/strong>&nbsp;that you may experience are the following:<\/p>\n\n\n\n<p><strong>Very common<\/strong>&nbsp;(may affect more than 1 user in 10):<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>Infusion reactions<\/strong>&nbsp;that may occur during the&nbsp;infusion&nbsp;itself&nbsp;or within 24 hours after the infusion: changes in heart rate, headache, rash, rash on the body, fever, hives, chills,&nbsp;itching&nbsp;,&nbsp;redness&nbsp;of the face and throat, feeling tired, nausea<\/li><li><strong>Infection&nbsp;you<\/strong>&nbsp;: respiratory infections such as colds and sinusitis, urinary tract infection, herpes infection<\/li><li>Decreased&nbsp;white blood cell count&nbsp;(&nbsp;lymphocyte&nbsp;,&nbsp;leukocyte&nbsp;,&nbsp;neutrophil&nbsp;)<\/li><li>Thyroid disorders such as overactive or underactive thyroid gland&nbsp;<\/li><\/ul>\n\n\n\n<p><strong>Common<\/strong>&nbsp;(may affect up to 1 in 10 people):<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>Infusion reactions<\/strong>&nbsp;that may occur during the&nbsp;infusion&nbsp;itself&nbsp;or within 24 hours after the infusion: indigestion, chest discomfort, pain, dizziness, taste changes, difficulty sleeping, difficulty breathing or shortness of breath, low&nbsp;blood pressure&nbsp;, pain at the infusion site.<\/li><li><strong>Infection&nbsp;you<\/strong>&nbsp;: cough, ear infection, flu-like disease,&nbsp;bronchitis&nbsp;<strong>,&nbsp;<\/strong>pneumonia&nbsp;,&nbsp;oral&nbsp;or&nbsp;vaginal&nbsp;sponge,&nbsp;shingles&nbsp;, cold sores, swollen or enlarged&nbsp;glands&nbsp;,&nbsp;flu&nbsp;,&nbsp;herpes&nbsp;zoster infection, tooth infection<\/li><li>excessive&nbsp;immune response<\/li><li>increased number of&nbsp;white blood cells&nbsp;such as&nbsp;neutrophil&nbsp;s,&nbsp;eosinophilic&nbsp;s (different types of&nbsp;white blood cells&nbsp;),&nbsp;anemia&nbsp;(&nbsp;anemia&nbsp;), reduced the percent of&nbsp;red cells&nbsp;, easy to get or excessive amount of bruising or bleeding, swelling of&nbsp;lymph nodes<\/li><li>pain in the back, neck, arms or legs, muscle aches, muscle cramps, joint pain, pain in the mouth or throat<\/li><li>inflammation&nbsp;of the mouth \/ gums \/ tongue<\/li><li>general discomfort, weakness, vomiting, diarrhea, abdominal pain, stomach flu, hiccups<\/li><li>abnormal liver samples<\/li><li>heartburn<\/li><li>abnormalities that can be seen on examination: blood or&nbsp;protein&nbsp;in the urine, decreased heart rate, irregular or abnormal heart rhythm, high&nbsp;blood pressure&nbsp;, impaired kidney function,&nbsp;white blood cells&nbsp;in the urine<\/li><li>bleeding in the skin<\/li><li>MS-&nbsp;forest<\/li><li>tremors, loss of sensation, burning or stinging sensation<\/li><li>autoimmune&nbsp;overactive or underactive&nbsp;thyroid gland&nbsp;,&nbsp;thyroid gland&nbsp;&#8211;&nbsp;antibodies&nbsp;or&nbsp;goiter&nbsp;(enlargement of the thyroid gland, which is located on the neck)<\/li><li>swollen arms and \/ or legs<\/li><li>vision problems,&nbsp;inflammation&nbsp;of the&nbsp;conjunctiva of the eye&nbsp;(&nbsp;conjunctivitis&nbsp;), eye diseases that are linked to diseases of the thyroid gland<\/li><li>tingling sensation or decreased balance,&nbsp;migraine<\/li><li>anxiety, depression<\/li><li>unusually heavy, prolonged or irregular menstrual bleeding<\/li><li>acne&nbsp;, reddening of the skin, excessive sweating, discoloration of the skin, skin damage,&nbsp;inflammation&nbsp;of the skin (&nbsp;dermatitis&nbsp;)<\/li><li>nosebleeds, bruises<\/li><li>hair loss<\/li><li>asthma<\/li><li>skeletal and muscle pain, discomfort in the pectoral muscle<\/li><\/ul>\n\n\n\n<p><strong>Uncommon<\/strong>&nbsp;(may affect up to 1 in 100 people):<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>Infection&nbsp;you<\/strong>&nbsp;: upset stomach, inflamed gums, nail fungus, tonsillitis,&nbsp;acute&nbsp;sinusitis, bacterial skin infection,&nbsp;infection&nbsp;with&nbsp;cytomegalovirus<\/li><li>Pneumonia<\/li><li>athlete&#8217;s foot<\/li><li>abnormal vaginal cell sample<\/li><li>increased sensation, sensory disturbances such as numbness, tingling and pain, tension headache<\/li><li>double vision<\/li><li>pain in the ear<\/li><li>difficulty swallowing, irritation of the throat, whooping cough<\/li><li>weight loss, weight gain, decreased&nbsp;red blood cell count&nbsp;, elevated blood sugar, enlargement of&nbsp;red blood cells<\/li><li>constipation, acid regurgitation,&nbsp;dry mouth<\/li><li>bleeding from the rectum<\/li><li>bleeding from the gums<\/li><li>decreased appetite<\/li><li>blisters, night sweats, swelling of the face,&nbsp;eczema<\/li><li>stiffness, discomfort in arms and legs<\/li><li>kidney stones&nbsp;, excretion of&nbsp;ketone bodies&nbsp;in urine, kidney disease<\/li><li>weakened \/ weakened immune system<\/li><li>tuberculosis<\/li><li>inflammation&nbsp;of the gallbladder, with or without&nbsp;gallstones&nbsp;s<\/li><li>warts<\/li><li>autoimmune diseases characterized by bleeding (acquired&nbsp;hemophilia&nbsp;,&nbsp;hemophilia&nbsp;A)<\/li><li>sarcoidosis<\/li><\/ul>\n\n\n\n<p><strong>Rare<\/strong>&nbsp;(may affect up to 1 in 1,000 people):<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>excessive activation of&nbsp;white blood cells&nbsp;in connection with&nbsp;inflammation&nbsp;(haemophagocytic lymphohistiocytosis)<\/li><li>autoimmune&nbsp;thrombotic&nbsp;disease&nbsp;(thrombotic thrombocytopenic purpura, TTP)<\/li><\/ul>\n\n\n\n<p><strong>Has been reported<\/strong>&nbsp;(occurs in an unknown number of users):<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>meningitis&nbsp;caused by listeria bacteria (&nbsp;meningitis&nbsp;)<\/li><li>bleeding in the lungs<\/li><li>heart attack<\/li><li>stroke<\/li><li>ruptures of carotid or vertebral arteries (blood vessels supplying the brain)<\/li><li>infection&nbsp;due to a&nbsp;virus&nbsp;called&nbsp;Epstein-Barr<\/li><\/ul>\n\n\n\n<p>Show the patient warning card and this leaflet to all physicians involved in your treatment, not just the neurologist.<\/p>\n\n\n\n<p>This information is also available on the patient warning card and in the patient guide provided to you by your doctor.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">How to store LEMTRADA<\/h2>\n\n\n\n<p>Keep this medicine out of the sight and reach of children.<\/p>\n\n\n\n<p>Do not use this medicine after the expiry date which is stated on the carton and vial after EXP.&nbsp;The expiration date is the last day of the specified month.<\/p>\n\n\n\n<p>Store in a refrigerator (2 \u00b0 C &#8211; 8 \u00b0 C).<\/p>\n\n\n\n<p>Do not freeze.<\/p>\n\n\n\n<p>Store in the original package.&nbsp;Sensitive to light.<\/p>\n\n\n\n<p>It is recommended that the drug be used immediately after dilution, due to the possible risk of\u00a0microbial\u00a0contamination.\u00a0If the medicine is not used immediately, it is the user&#8217;s responsibility to ensure that the storage time during use and the conditions before use do not exceed 8 hours at 2 till to 8 \u00baC, protected from light.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Contents of the pack and other information<\/h2>\n\n\n\n<h2 class=\"wp-block-heading\">Content declaration<\/h2>\n\n\n\n<p>The&nbsp;<strong>active substance<\/strong>&nbsp;is alemtuzumab.<br>Each&nbsp;vial&nbsp;contains 12 mg of alemtuzumab in 1.2 ml.<\/p>\n\n\n\n<p>Other&nbsp;<strong>ingredients<\/strong>&nbsp;are:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>disodium phosphate dihydrate (E339)<\/li><li>disodium edetate<\/li><li>potassium chloride (E508)<\/li><li>potassium dihydrogen phosphate (E340)<\/li><li>polysorbate 80 (E433)<\/li><li>sodium chloride<\/li><li>water for injections<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">What the medicine looks like and contents of the pack<\/h2>\n\n\n\n<p>LEMTRADA is a clear, colorless to slightly yellow concentrate for&nbsp;solution&nbsp;for&nbsp;infusion&nbsp;(sterile concentrate) that is supplied in a&nbsp;glass&nbsp;vial&nbsp;with a stopper.<\/p>\n\n\n\n<p>There is 1&nbsp;vial&nbsp;in each carton.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Marketing Authorisation Holder<\/h2>\n\n\n\n<p>Sanofi Belgium<\/p>\n\n\n\n<p>Leonardo Da Vincilaan 19<\/p>\n\n\n\n<p>B-1831 Diegem<\/p>\n\n\n\n<p>Belgium<\/p>\n\n\n\n<p><strong>Manufacturer<\/strong><\/p>\n\n\n\n<p>Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, UK.<\/p>\n\n\n\n<p>Genzyme Ireland Limited, IDA Industrial Park, Old Kilmeaden Road, Waterford, Ireland.<\/p>\n\n\n\n<p>Contact the representative of the marketing authorization holder if you want to know more about this medicine:<br><br>Sanofi AB<\/p>\n\n\n\n<p>Tel: +46 (0) 8 634 50 00<\/p>\n","protected":false},"excerpt":{"rendered":"<p>LEMTRADA contains the active substance alemtuzumab used to treat a form of multiple sclerosis (MS) in adults, called relapsing-remitting multiple sclerosis (RRMS, relapsing remitting MS). LEMTRADA does not cure MS, but can reduce the number of relapses of MS. LEMTRADA can also help slow down or reverse certain signs and symptoms of MS. In clinical trials , patients treated with LEMTRADA had fewer relapses and were less likely to have impaired function compared with patients treated with a beta- interferon injected several times a week.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"cybocfi_hide_featured_image":"","footnotes":""},"categories":[2200,15579],"tags":[15489,15492,15493,15498,15494,15497,15491,15490,15495,15496],"class_list":["post-16339","post","type-post","status-publish","format-standard","hentry","category-medicines","category-l","tag-alemtuzumab","tag-alemtuzumab-side-effects","tag-benefits-of-alemtuzumab","tag-benefits-of-lemtrada","tag-lemtrada","tag-lemtrada-side-effects","tag-what-alemtuzumab-is-used-for","tag-what-is-alemtuzumab","tag-what-is-lemtrada","tag-what-lemtrada-is-used-for"],"_links":{"self":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/16339","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/comments?post=16339"}],"version-history":[{"count":5,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/16339\/revisions"}],"predecessor-version":[{"id":16381,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/16339\/revisions\/16381"}],"wp:attachment":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/media?parent=16339"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/categories?post=16339"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/tags?post=16339"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}